Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05641324
Title A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Anaveon AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | ESP | DNK | DEU | CHE

Facility Status City State Zip Country Details
Vejle Hospital Vejle Denmark Details
Institut Paoli-Calmettes Marseille France Details
CHU de Nantes - Hôtel-Dieu Nantes France Details
Institut de cancérologie Strasbourg Europe (ICANS) Strasbourg France Details
Universitätsklinikum Jena Jena 07747 Germany Details
Hospital Clinic Barcelona Barcelona Spain Details
Hospital Universitario La Princesa Madrid 28006 Spain Details
Hospital General Universitario Morales Meseguer Murcia Spain Details
Hospital Clinico Universitario de Salamanca Salamanca Spain Details
Inselspital, Universitätsspital Bern Bern Switzerland Details
Kantonsspital St. Gallen Saint Gallen Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field